Cargando…
Subcutaneous immunoglobulin replacement therapy in a heart transplant recipient with severe recurrent infections
Intravenous immunoglobulin has been shown to decrease the risk of post-transplant infections in heart recipients with IgG hypogammaglobulinemia, however the use of subcutaneous immunoglobulin has not been reported. We report on immune reconstitution, clinical efficacy and tolerability of subcutaneou...
Autores principales: | Carbone, Javier, Palomo, Jesus, Fernandez-Yañez, Juan, Sarmiento, Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
EDIMES Edizioni Internazionali Srl
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593014/ https://www.ncbi.nlm.nih.gov/pubmed/26495272 |
Ejemplares similares
-
Two consecutive recurrences of crescentic immunoglobulin A nephropathy in a renal transplant recipient
por: Gopalakrishnan, N., et al.
Publicado: (2016) -
Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease
por: Skoda-Smith, Suzanne, et al.
Publicado: (2010) -
Controversies about immunoglobulin replacement therapy in HSCT recipients with hypogammaglobulinemia
por: Ohmoto, Akihiro, et al.
Publicado: (2022) -
Clinical significance of serum galactose-deficient immunoglobulin A1 for detection of recurrent immunoglobulin A nephropathy in kidney transplant recipients
por: Park, Woo Yeong, et al.
Publicado: (2021) -
Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies
por: Canessa, Clementina, et al.
Publicado: (2016)